Research and Markets: Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a65afa/advanced_3d4d_v) has announced the addition of Frost & Sullivan's new report "Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe" to their offering.

“Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe”

Significant Operational Gains and Enhanced Patient Safety Promote Appeal of Advanced (3D/4D) Visualisation and Clinical Applications

Hospital end users are becoming increasingly receptive to the expanded range of clinically specific 3D/4D applications that imaging companies offer over and above generic 3D imaging capabilities. These include publicity-attracting procedures such as virtual colonoscopy and CT and MR angiography, which coupled with a dynamic patient archiving and communications systems (PACS) market, and boosted by healthcare authority investment in the digitisation of patient data represents great potential for the future growth of 3D/4D imaging companies. The primary advantage of advanced (3D/4D) visualisation and clinical applications is that the digital image can be manipulated, notes the analyst of this research. For example, an area can be magnified or the contrast and density can be changed to enhance the quality of the image.

Digital images are more tolerant of over- and under-exposure, which minimises the need for repeat studies. Computer-aided detection can also be applied to aid decision making. Image manipulation capabilities will be a major driver for using advanced (3D/4D) visualisation and clinical applications. In addition, the actual patient safety and operational gains made possible by advanced (3D/4D) visualisation and clinical applications are significant, adds the analyst. The drive to improve precision and accuracy through standardised methods and advanced image analysis ultimately leads to improved patient safety, reduced turnaround times and reduced cost per examination.

Supportive Policies and Financial Incentives to Accelerate and Widen Adoption

Healthcare organisations across Europe have their budgets pre-planned for specific activities, and advanced visualisation vendors recognise the lack of funding for large-scale projects. This difficulty of securing funding, combined with the scarcity of internal resources within hospitals, can cause long delays in sales cycles and can even result in projects being postponed. Despite the evolution of advanced visualisation solutions towards being multi-modality, enterprise-wide solutions, there remains a strong correlation today between the sale of these solutions and the sale of new CT imaging equipment, which more often than not is sold with an advanced imaging and 3D image reconstruction solution, explains the analyst. This dependence on CT is expected to have a negative impact on the advanced visualisation (3D/4D) market as sales of new high-end scanners have shown signs of slowing down over the next few years.

Many organisations do not recognise a clear business case for financial and organisational investments in advanced (3D/4D) visualisation and clinical applications for medical imaging. 3D/4D vendors need to collaborate with end users to address those issues and demonstrate a clear ROI. As in the case for other healthcare information technologies, the costs associated with advanced (3D/4D) visualisation and clinical applications implementation are typically borne primarily by healthcare organisations, while many of the benefits accrue to patients, payers and society as a whole in terms of improved healthcare. Supportive policies and new financial incentives would help to redress these deficiencies and accelerate the more widespread adoption of 3D/4D tools.

Key Topics Covered:

1. Executive Summary

2. Research Scope and Methodology

3. Introduction and Background

4. Market Dynamics

5. Total Market Measurements

6. Market Segmentation by Solution Component

7. Market Segmentation by Solution Type

8. Market Segmentation by Hospital Type

9. Market Segmentation by Tier of Competition/Sales Channel

10. Modality Trends

11. Competitive Overview